BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 943180)

  • 21. Radioimmunoassay of human fibrinopeptide A.
    Nossel HL; Younger LR; Wilner GD; Procupez T; Canfield RE; Butler VP
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2350-3. PubMed ID: 5289869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of NH2-terminal fibrinogen B beta fragments from N-DSK of human fibrinogen.
    Birken S; Agosto G; Lahiri B; Canfield R
    Thromb Haemost; 1984 Feb; 51(1):16-21. PubMed ID: 6232727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42.
    Weitz JI; Koehn JA; Canfield RE; Landman SL; Friedman R
    Blood; 1986 Apr; 67(4):1014-22. PubMed ID: 2937467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
    Plow E; Edgington TS
    J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic determinants in the disulfide regions of bovine fibrinogen.
    Timpl R; Hahn E; Gollwitzer R
    Eur J Biochem; 1975 Feb; 51(2):617-23. PubMed ID: 50233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
    Olexa SA; Budzynski AZ
    Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the iodination of tyrosines in the amino terminal domain of fibrinogen and in N-DSK and fibrin-N-DSK.
    York JL
    Thromb Res; 1983 Jul; 31(2):203-9. PubMed ID: 6636042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antigenic determinant of the LH-releasing hormone for three different antisera.
    Arimura A; Sato H; Coy DH; Worobec RB; Schally AV; Yanaihara N; Hashimoto T; Yanaihara C; Sukura N
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):222-31. PubMed ID: 47682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical mapping of the conformation of human fibrinogen. The gamma 95-264 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage.
    Fair DS; Edgington TS; Plow EF
    J Biol Chem; 1981 Aug; 256(15):8018-23. PubMed ID: 6167572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of antigenic determinants in the amino-terminal region of bovine fibrinogen Aalpha chain.
    Tanswell P; Reiter H; Timpl R
    Eur J Biochem; 1978 Aug; 88(2):565-71. PubMed ID: 80317
    [No Abstract]   [Full Text] [Related]  

  • 31. Sequence of plasmin proteolysis at the NH2-terminus of the b beta-chain of human fibrinogen.
    Koehn JA; Hurlet-Jensen A; Nossel HL; Canfield RE
    Anal Biochem; 1983 Sep; 133(2):502-10. PubMed ID: 6227262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic structure of the cyanogen bromide peptide F-CB3 from fibrinogen alpha-chain.
    Lotter H; Timpl R
    Eur J Biochem; 1975 Dec; 60(1):221-6. PubMed ID: 54258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of antisera to synthetic 1-34 human parathyroid hormone fragments: possible implications for the correctness of proposed structures.
    Visser TJ; Buurman CJ; Birkenhäger JC
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):90-102. PubMed ID: 760361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmic degradation of human fibrinogen. III. Molecular model of the plasmin-resistant disulfide knot in monomeric fragment D.
    Furlan M; Kemp G; Beck EA
    Biochim Biophys Acta; 1975 Jul; 400(1):95-111. PubMed ID: 125109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymic and immunochemical properties of lysozyme. XIII. Accurate delineation of the reactive site around the disulfide 6-127 by immunochemical study of beta-propiolactone lysozyme derivative and of synthetic disulfide peptides.
    Atassi MZ; Koketsu J; Habeeb AF
    Biochim Biophys Acta; 1976 Feb; 420(2):358-75. PubMed ID: 943182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments.
    Takagi T; Doolittle RF
    Biochemistry; 1975 Mar; 14(5):940-6. PubMed ID: 123758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a synthetic homologue of human fibrinopeptide A for production of a monoclonal antibody specific for the free peptide.
    Kudryk B; Gidlund M; Rohoza A; Ahadi M; Coiffe D; Weitz JI
    Blood; 1989 Aug; 74(3):1036-44. PubMed ID: 2752151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acid sequences of lamprey fibrinopeptides A and B and characterizations of the junctions split by lamprey and mammalian thrombins.
    Cottrell BA; Doolittle RF
    Biochim Biophys Acta; 1976 Dec; 453(2):426-38. PubMed ID: 999898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.